Funds and ETFs CureVac N.V.

Equities

CVAC

NL0015436031

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:00 2024-06-13 pm EDT 5-day change 1st Jan Change
4 USD -3.61% Intraday chart for CureVac N.V. -19.84% -4.99%
CureVac AG is a clinical-stage biopharmaceutical company, The Company strives to create transformative medicines to protect and improve people’s lives. Fueled by proprietary RNA technology platform combined with two decades of science and manufacturing, The Company is dedicated to creating novel treatments that enable the body to make its own prophylactic and therapeutic drugs.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
3.716 EUR
Average target price
8.728 EUR
Spread / Average Target
+134.87%
Consensus
  1. Stock Market
  2. Equities
  3. CVAC Stock
  4. Funds and ETFs CureVac N.V.